💡💡Complete our 10 minute survey before it closes to help shape future research! 💡💡
Complete here: https://t.co/TulXRtMoiW
@LindAlliance@WellbeingofWmen@BritFertSoc
@SIGFertPreser
The Incidence, Characteristics, Management and Outcomes of Peripartum Hyponatraemia in the United Kingdom: A Prospective Study Using the UK Obstetric Surveillance System (UKOSS)
https://t.co/RerdMUW4kc
The Incidence, Characteristics, Management and Outcomes of Peripartum Hyponatraemia in the United Kingdom: A Prospective Study Using the UK Obstetric Surveillance System (UKOSS)
https://t.co/RerdMUW4kc
Fewer cases were submitted than predicted; many were submitted without documented symptoms. Cases may have been missed as symptoms were not documented or misdiagnosed reducing the calculated incidence.
The Incidence, Characteristics, Management and Outcomes of Peripartum Hyponatraemia in the United Kingdom: A Prospective Study Using the UK Obstetric Surveillance System (UKOSS)
https://t.co/RerdMUW4kc
🌟 New in @BJOGTweets: A retrospective analysis found that 2 in 100 patients suffered major adverse cardiovascular events — such as pulmonary edema — following postpartum hemorrhage. Patients with MACE had more preeclampsia (30%) than those without (10%). https://t.co/gTtVfBzQco
Improving Aspirin Adherence for Effective Pre-Eclampsia Prevention
https://t.co/vvkFEOxgko
In our @BJOGT letter, we stress: aspirin can prevent pre-eclampsia only if taken.
Trial adherence ≠ real-world use.
If you’ve been told to take aspirin during pregnancy, it can help reduce the risk of pre-eclampsia, but only if you take it regularly. Some pregnant women and people don’t know why or how to take it. Pills can be hard to access, routines tough to build, and advice unclear.